Market Overview:
The global non-opioid pain relief device market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic pain, rising geriatric population, and technological advancements in non-opioid pain relief devices. Based on type, the global non-opioid pain relief device market is segmented into implantable devices, non-implantable devices, radiofrequency ablation (RFA), and other emerging technologies. The implantable devices segment is expected to grow at the highest CAGR during the forecast period owing to its advantages such as long lasting effects and fewer side effects as compared to other types of therapies.
Product Definition:
A non-opioid pain relief device is a tool that can be used to help manage pain. Non-opioid pain relief devices may include things like ice packs, heating pads, or electrical stimulation machines. These devices can be helpful in managing ongoing pain and reducing the need for prescription opioids.
Implantable Device:
An implantable device is a medical device that is placed inside the body. Implantable devices are used for various medical conditions such as cardiovascular diseases, diabetes, and pain management among others. The growing prevalence of chronic disorders has led to an increase in demand for effective treatment options which has further increased the demand for innovative and effective implantable devices available in the market.
Non-Implantable Device:
Non-implantable devices are used to relieve chronic pain by delivering electrical stimulation, magnetic field therapy, or ultrasound. The market is expected to grow at a lucrative rate owing to the increasing prevalence of chronic pain disorders and rising awareness about these new treatment options. According to the CDC in 2016 around 20% of adults in U.
Application Insights:
Based on application, the global non-opioid pain relief device market is segmented into hospitals, pain management centers and homecare. The hospital segment dominated the market in 2017 due to factors such as increasing prevalence of chronic diseases and growing geriatric population. According to a study published by the CDC in 2014, around 1 in 5 adults suffer from chronic pain every year and it was estimated that around 40 million U.S. adults would experience chronic pain by 2040 if current trends continue. This is expected to drive demand for non-opioid analgesic drugs which will further fuel growth during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to high awareness levels about chronic pain and opioid addiction, presence of well-established healthcare facilities, availability of highly skilled physicians, and favorable reimbursement policies & regulatory reforms by governments.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising geriatric population prone to chronic pain conditions coupled with increasing disposable income levels in emerging economies such as China & India. In addition, growing medical tourism industry due to low cost of treatment in countries like Thailand & Malaysia are expected boost demand for these devices during the forecast period.
Growth Factors:
- Increasing incidence of chronic pain: The global prevalence of chronic pain is estimated to be around 20%. This number is expected to grow in the coming years due to the increasing aging population and rising rates of lifestyle-related diseases. This will create a large pool of patients who are in need of effective non-opioid pain relief devices.
- Growing awareness about the dangers of opioids: There has been a growing awareness about the dangers associated with opioid use in recent years. This has led to a shift towards using non-opioid alternatives for pain relief, creating demand for non-opioid pain relief devices.
- Technological advancements: The development and commercialization of new technologies has been key to driving growth in many industries, and the non-opioid pain relief device market is no exception. Ongoing technological advancements are helping manufacturers develop better and more effective devices, which is resulting in increased adoption by patients and healthcare professionals alike.
- Rising healthcare costs: Healthcare costs have been on the rise globally in recent years, putting pressure on both patients and healthcare providers alike to find cost-effective solutions for managing various health conditions, including chronic pain management . Non-opioid Pain Relief Devices offer such an option, making them an increasingly attractive choice for both groups.. 5) Emerging markets: A large portion of the world’s population resides in emerging markets such as China, India, Brazil etc., where there is still significant room for
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-Opioid Pain Relief Device Market Research Report
By Type
Implantable Device, Non-Implantable Device, Radiofrequency Ablation, Other Emerging Technologies
By Application
Hospitals, Pain Management Centers, Homecare
By Companies
Abbott Laboratories, Bayer AG, Bioelectronics Corporation, Boston Scientific Corporation, Medtronic plc, Koninklijke Philips N.V., NeuroMetrix Inc., Nuvectra Corporation, Omron Corporation, Stryker Corporation, SPR Therapeutics, LLC, Stimwave LLC, Thermotek Inc., Zynex Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
195
Number of Tables & Figures
137
Customization Available
Yes, the report can be customized as per your need.
Global Non-Opioid Pain Relief Device Market Report Segments:
The global Non-Opioid Pain Relief Device market is segmented on the basis of:
Types
Implantable Device, Non-Implantable Device, Radiofrequency Ablation, Other Emerging Technologies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Pain Management Centers, Homecare
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Bayer AG
- Bioelectronics Corporation
- Boston Scientific Corporation
- Medtronic plc
- Koninklijke Philips N.V.
- NeuroMetrix Inc.
- Nuvectra Corporation
- Omron Corporation
- Stryker Corporation
- SPR Therapeutics, LLC
- Stimwave LLC
- Thermotek Inc.
- Zynex Medical
Highlights of The Non-Opioid Pain Relief Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Implantable Device
- Non-Implantable Device
- Radiofrequency Ablation
- Other Emerging Technologies
- By Application:
- Hospitals
- Pain Management Centers
- Homecare
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-Opioid Pain Relief Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A non-opioid pain relief device is a type of medication that does not contain opioids. These medications can be used to relieve pain without the side effects associated with opioid use, such as addiction and overdose. Non-opioid pain relief devices can include over-the-counter medications, prescription drugs, and devices like heat pads or ice packs.
Some of the major companies in the non-opioid pain relief device market are Abbott Laboratories, Bayer AG, Bioelectronics Corporation, Boston Scientific Corporation, Medtronic plc, Koninklijke Philips N.V., NeuroMetrix Inc., Nuvectra Corporation, Omron Corporation, Stryker Corporation, SPR Therapeutics, LLC, Stimwave LLC, Thermotek Inc., Zynex Medical.
The non-opioid pain relief device market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Non-Opioid Pain Relief Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Non-Opioid Pain Relief Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Non-Opioid Pain Relief Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Non-Opioid Pain Relief Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Non-Opioid Pain Relief Device Market Size & Forecast, 2020-2028
4.5.1 Non-Opioid Pain Relief Device Market Size and Y-o-Y Growth
4.5.2 Non-Opioid Pain Relief Device Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Implantable Device
5.2.2 Non-Implantable Device
5.2.3 Radiofrequency Ablation
5.2.4 Other Emerging Technologies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Pain Management Centers
6.2.3 Homecare
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Non-Opioid Pain Relief Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Non-Opioid Pain Relief Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Implantable Device
9.6.2 Non-Implantable Device
9.6.3 Radiofrequency Ablation
9.6.4 Other Emerging Technologies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Pain Management Centers
9.10.3 Homecare
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Implantable Device
10.6.2 Non-Implantable Device
10.6.3 Radiofrequency Ablation
10.6.4 Other Emerging Technologies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Pain Management Centers
10.10.3 Homecare
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Implantable Device
11.6.2 Non-Implantable Device
11.6.3 Radiofrequency Ablation
11.6.4 Other Emerging Technologies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Pain Management Centers
11.10.3 Homecare
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Implantable Device
12.6.2 Non-Implantable Device
12.6.3 Radiofrequency Ablation
12.6.4 Other Emerging Technologies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Pain Management Centers
12.10.3 Homecare
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Implantable Device
13.6.2 Non-Implantable Device
13.6.3 Radiofrequency Ablation
13.6.4 Other Emerging Technologies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Pain Management Centers
13.10.3 Homecare
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Non-Opioid Pain Relief Device Market: Competitive Dashboard
14.2 Global Non-Opioid Pain Relief Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Bayer AG
14.3.3 Bioelectronics Corporation
14.3.4 Boston Scientific Corporation
14.3.5 Medtronic plc
14.3.6 Koninklijke Philips N.V.
14.3.7 NeuroMetrix Inc.
14.3.8 Nuvectra Corporation
14.3.9 Omron Corporation
14.3.10 Stryker Corporation
14.3.11 SPR Therapeutics, LLC
14.3.12 Stimwave LLC
14.3.13 Thermotek Inc.
14.3.14 Zynex Medical
